Frank C. Sparks

1.8k citations
30 papers · 1.4k indexed · h-index 16

Frank C. Sparks

30 papers receiving 1.2k citations

Peers

Frank C. Sparks
Comparison fields: 5 of 95
  • Oncology 793
  • Immunology 533
  • Biotechnology 86
  • Hepatology 77
  • Otorhinolaryngology 33
Replace Daniel E. Lehane with:
Daniel E. Lehane United States
Derek Crowther United Kingdom
Soji F. Oluwole United States
WE Fibbe Netherlands
Ryo Konno Japan
M. Vincent United States
Anne Angiolillo United States
C. Kortsik Germany
Jean Schlumberger France
Michael Conner United States
Frank C. Sparks relative to Daniel E. Lehane United States Daniel E. Lehane's profile →
Citations per field
00.5×4.8×
Daniel E. Lehane · 1×
Citations per year

Countries citing papers authored by Frank C. Sparks

Since Specialization
Citations

This map shows the geographic impact of Frank C. Sparks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank C. Sparks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank C. Sparks more than expected).

Fields of papers citing papers by Frank C. Sparks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank C. Sparks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank C. Sparks. The network helps show where Frank C. Sparks may publish in the future.

Co-authorship network

The 24 scholars most cited alongside Frank C. Sparks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frank C. Sparks Line = papers co-authored together Frank C. Sparks links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 198611
2 198346
3 19823
4 1979138
5 19792
6 19787
7
Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer.
197711
8 19776
9 197756
10 197612
11 1976131
12 197648
13 197615
14 19759
15 197513
16 197550
17 197559
18 1974333
19 197428
20 1973171

About Frank C. Sparks

Frank C. Sparks is a scholar working on Oncology, Immunology and Hepatology, having authored 30 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (7 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Immune responses and vaccinations (5 papers), Viral-associated cancers and disorders (4 papers), Cancer Research and Treatments (3 papers), Neonatal Respiratory Health Research (3 papers) and Cancer-related cognitive impairment studies (3 papers). The work is most often cited by research in Oncology (793 citations), Immunology (533 citations) and Biotechnology (86 citations). Frank C. Sparks has collaborated with scholars based in United States. Frequent co-authors include Donald L. Morton, Frederick R. Eilber, Beth E. Meyerowitz, Melvin J. Silverstein, John S. Hunt, E. Carmack Holmes, Alfred S. Ketcham, Kenneth P. Ramming, Yosef H. Pilch and Charles M. Haskell. Their work appears in journals such as New England Journal of Medicine, JNCI Journal of the National Cancer Institute and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026